2026 NPPES data Medical Oncology Physician NPI 1407852676 MD
Verify on CMS →

STEPHEN ZRADA, MD

Medical Oncology Physician in CHERRY HILL, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
762
Medicare Part D claims · 245 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.934/100
▼ 3 pts below national avg 83.1 · [object Object]
Industry payments
$6.1K
29 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

STEPHEN ZRADA, MD reported a CMS MIPS final score of 79.934/100 — below the 83.1 national average — and filed 762 Medicare Part D claims in 2023.

79.934/100
MIPS score · -3 vs avg
762
Part D claims, 2023
80%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEPHEN ZRADA, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

80 30th percentile higher than 30% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

STEPHEN ZRADA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about STEPHEN ZRADA, MD?

Near national average

NPI registry status

Active

Issued 06/22/2005

NPI 1407852676

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

762 11% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

79.934/100 3.165999999999997% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New Jersey

How Medical Oncology Physician compares to other specialties among New Jersey providers

New Jersey providers

Medical Oncology Physician share within New Jersey

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within New Jersey

Medicare quality performance — MIPS

STEPHEN ZRADA, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average

Near national average
MIPS Final Score
79.934/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) — 79.934/100 vs national avg 83.1

0%100%National avg83%79.9%
MIPS final score (Medical Oncology Physician) — 79.934/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEPHEN ZRADA, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 1865 ROUTE 70 EAST, CHERRY HILL, NJ, 08003, with a listed phone of (856) 429-1519. NPI 1407852676 was issued on 06/22/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZRADA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 762 prescription claims written by this provider, covering 245 Medicare beneficiaries and totaling roughly $1.9 million in drug spend, split 20% brand-name and 80% generic by claim count, with an opioid prescribing rate of 3.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.934/100 for the 2023 performance year (Quality 63.5163), compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1865 ROUTE 70 EAST
CHERRY HILL, NJ 08003

Provider Details

NPI 1407852676
Specialty Medical Oncology Physician
Credentials MD
Gender Male
NPI Issued 06/22/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

79.934
Final Score
Avg: 83.1
63.5163
Quality
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where STEPHEN ZRADA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC
SEWELL, NJ
CLINICAL HEALTHCARE ASSOCIATES OF NEW JERSEY SPECIALTY PRACTICES PC
SEWELL, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEPHEN ZRADA, MD. Source: openpaymentsdata.cms.gov.

Total received

$6.1K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

STEPHEN ZRADA, MD — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 762 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

762
Total Claims
$1.9M
Total Drug Cost
245
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,376
Total Day Supply
36,271
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$1.8M
Generic Drug Cost
$118K
Opioid Claims
23 (3.0% rate)

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
1.73
Gender Split
77% female / 23% male
Age Distribution
<65: 14, 65-74: 122, 75-84: 96, 85+: 13

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What STEPHEN ZRADA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
194
Ondansetron Hcl
76
Prochlorperazine Maleate
61
Letrozole
50
Hydroxyurea
34
Exemestane
30
Imbruvica
Ibrutinib
21
Lidocaine-Prilocaine
Lidocaine/Prilocaine
15
Ibrance
Palbociclib
14
Calquence
Acalabrutinib Maleate
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How STEPHEN ZRADA, MD fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

STEPHEN ZRADA, MD's 762 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as ZRADA.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEPHEN ZRADA, MD's specialty?
STEPHEN ZRADA, MD specializes in Medical Oncology Physician and practices in CHERRY HILL, New Jersey. Credentials: MD.
How much does STEPHEN ZRADA, MD prescribe under Medicare Part D?
In 2023, STEPHEN ZRADA, MD wrote 762 Medicare Part D claims totaling $1.9M in drug costs for 245 beneficiaries.
What is STEPHEN ZRADA, MD's Medicare quality score?
STEPHEN ZRADA, MD has a CMS MIPS Final Score of 79.934/100 (Quality: 63.5163). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is STEPHEN ZRADA, MD located?
STEPHEN ZRADA, MD is located at 1865 ROUTE 70 EAST, CHERRY HILL, NJ, 08003. Phone: (856) 429-1519.
What is STEPHEN ZRADA, MD's NPI number?
STEPHEN ZRADA, MD's National Provider Identifier (NPI) is 1407852676, issued on 06/22/2005.
Does STEPHEN ZRADA, MD prescribe more brand-name or generic drugs?
STEPHEN ZRADA, MD's prescribing is 20% brand-name and 80% generic drugs by claim count, with $1.8M in brand drug costs.
Does STEPHEN ZRADA, MD prescribe opioids?
Yes, STEPHEN ZRADA, MD had 23 opioid claims in 2023 with an opioid prescribing rate of 3.0%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does STEPHEN ZRADA, MD prescribe most often?
Based on 2023 Medicare Part D data, STEPHEN ZRADA, MD's most frequently prescribed drugs include Anastrozole, Ondansetron Hcl, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEPHEN ZRADA, MD accept Medicare?
STEPHEN ZRADA, MD appears in CMS Medicare data with 762 Part D claims and 245 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEPHEN ZRADA, MD's credentials?
STEPHEN ZRADA, MD's NPI is 1407852676 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology